FR2959414B1 - Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire - Google Patents
Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaireInfo
- Publication number
- FR2959414B1 FR2959414B1 FR1053355A FR1053355A FR2959414B1 FR 2959414 B1 FR2959414 B1 FR 2959414B1 FR 1053355 A FR1053355 A FR 1053355A FR 1053355 A FR1053355 A FR 1053355A FR 2959414 B1 FR2959414 B1 FR 2959414B1
- Authority
- FR
- France
- Prior art keywords
- refractory
- volemie
- cardiogenic
- asthmatic
- anaphylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1053355A FR2959414B1 (fr) | 2010-04-30 | 2010-04-30 | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire |
US13/168,889 US8846606B2 (en) | 2010-04-30 | 2011-06-24 | Method and drug composition for treating septic shock hypotension |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1053355A FR2959414B1 (fr) | 2010-04-30 | 2010-04-30 | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2959414A1 FR2959414A1 (fr) | 2011-11-04 |
FR2959414B1 true FR2959414B1 (fr) | 2016-01-08 |
Family
ID=43086528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1053355A Expired - Fee Related FR2959414B1 (fr) | 2010-04-30 | 2010-04-30 | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire |
Country Status (2)
Country | Link |
---|---|
US (1) | US8846606B2 (fr) |
FR (1) | FR2959414B1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
WO2015089494A1 (fr) * | 2013-12-13 | 2015-06-18 | Ankenman Ralph | Compositions et méthodes pour le traitement de systèmes déréglés |
CN112546197A (zh) * | 2013-12-18 | 2021-03-26 | 乔治华盛顿大学国会特许非营利公司 | 血管紧张素ii单独或以组合方式用于治疗低血压 |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
CN113164550A (zh) * | 2018-11-15 | 2021-07-23 | 费灵有限公司 | 用于治疗败血症的化合物、组合物和方法 |
-
2010
- 2010-04-30 FR FR1053355A patent/FR2959414B1/fr not_active Expired - Fee Related
-
2011
- 2011-06-24 US US13/168,889 patent/US8846606B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20110269666A1 (en) | 2011-11-03 |
US8846606B2 (en) | 2014-09-30 |
FR2959414A1 (fr) | 2011-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2959414B1 (fr) | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire | |
LTPA2017019I1 (lt) | Žmogaus antikūnai, pasižymintys dideliu giminingumu PCSK9 | |
CY2016030I2 (el) | Αντισωματα εναντι της il-17 | |
DE502006004066D1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
EP2279003A4 (fr) | Anticorps anti-cd137 en tant qu'agent dans le traitement d'états inflammatoires | |
CY2016017I2 (el) | Συνθεση για θεραπεια πνευμονικης υπερτασης | |
FR2928832B1 (fr) | Orthese de poignet, destinee au traitement du syndrome du canal carpien | |
DK1889065T3 (da) | Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent | |
BR112012000735A2 (pt) | "métodos, kits e conjuntos de compostos" | |
MA29098B1 (fr) | Compositions pour le traitement du vhc | |
FR2929661B1 (fr) | Retenue axiale d'aubes de compresseur. | |
MA34263B1 (fr) | Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs) | |
FR2929946B1 (fr) | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer | |
FR2907011B1 (fr) | Utilisation de la citrulline pour le traitement des etats de denutrition | |
SMT201400177B (it) | Diagnosi e trattamenti di carcinoma basati sul genotipo di odc1 | |
DK2107870T3 (da) | Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom | |
BRPI0923220A2 (pt) | dispositivo e processo de fabricação de uma lona de reforço. | |
DK3326681T3 (da) | Indretning til behandling af analsphincteren | |
BRPI0909895A2 (pt) | "sistema iniciador e composição endurecível" | |
LTPA2016019I1 (lt) | Išsėtinės sklerozės (MS) gydymas kampatu-1H | |
DE602006004175D1 (de) | Gerät zur Bestimmung der Keulenrichtung | |
DK2328553T3 (da) | Corticosteroider til behandling af inflammatoriske sygdomme i mave-tarm-kanalen | |
DE602006021105D1 (de) | Nachbehandlung eines Abgasstroms | |
DE502006007167D1 (de) | Gehäuse für eine abgasbehandlungskomponente mit verstärkungshülse | |
RU2009133559A (ru) | Способ обработки деталей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
CA | Change of address |
Effective date: 20160906 |
|
ST | Notification of lapse |
Effective date: 20171229 |